Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-04-11 09:01 am Purchase | 13G | SPRINGWORKS THERAPEUTICS INC C SWTX | FMR LLC | 6,046,209 12.253% | 2,099,889 (+53.21%) | View |
| 2022-02-14 9:12 pm Purchase | 13G | SPRINGWORKS THERAPEUTICS INC C SWTX | PERCEPTIVE ADVISORS LLC | 4,849,912 9.8% | 672,191 (+16.09%) | View |
| 2022-02-11 7:01 pm Sale | 13G | SPRINGWORKS THERAPEUTICS INC C SWTX | PFIZER INC PFE | 2,340,330 4.75% | -2,242,717 (-48.94%) | View |
| 2022-02-10 08:37 am Purchase | 13G | SPRINGWORKS THERAPEUTICS INC C SWTX | VANGUARD GROUP INC | 2,862,312 5.81% | 2,862,312 (New Position) | View |
| 2022-02-09 10:01 am Purchase | 13G | SPRINGWORKS THERAPEUTICS INC C SWTX | FMR LLC | 3,946,320 8.012% | 568,300 (+16.82%) | View |
| 2021-08-12 5:07 pm Sale | 13D | SPRINGWORKS THERAPEUTICS INC C SWTX | BC SW LP | 4,831,307 9.8% | -1,000,000 (-17.15%) | View |
| 2021-03-11 4:30 pm Sale | 13D | SPRINGWORKS THERAPEUTICS INC C SWTX | BC SW LP | 5,831,307 11.9% | -1,450,000 (-19.91%) | View |
| 2021-03-03 6:50 pm Sale | 13D | SPRINGWORKS THERAPEUTICS INC C SWTX | ORBIMED ADVISORS LLC | 6,186,307 12.6% | -1,220,000 (-16.47%) | View |
| 2021-02-16 3:35 pm Purchase | 13G | SPRINGWORKS THERAPEUTICS INC C SWTX | PERCEPTIVE ADVISORS LLC | 4,177,721 8.6% | 880,199 (+26.69%) | View |
| 2021-02-12 5:08 pm Sale | 13G | SPRINGWORKS THERAPEUTICS INC C SWTX | PFIZER INC PFE | 4,583,047 9.4% | -10,800 (-0.24%) | View |
| 2021-02-11 5:16 pm Sale | 13G | SPRINGWORKS THERAPEUTICS INC C SWTX | BIOTECHNOLOGY VALUE FUND L P | 50 1% | -3,079,105 (-100.00%) | View |
| 2021-02-08 10:33 am Purchase | 13G | SPRINGWORKS THERAPEUTICS INC C SWTX | FMR LLC | 3,378,020 6.926% | 3,378,020 (New Position) | View |
| 2020-10-15 5:20 pm Unchanged | 13D | SPRINGWORKS THERAPEUTICS INC C SWTX | BC SW LP | 7,281,307 15% | 0 (Unchanged) | View |
| 2020-10-13 9:14 pm Unchanged | 13D | SPRINGWORKS THERAPEUTICS INC C SWTX | ORBIMED ADVISORS LLC | 7,406,307 15.5% | 0 (Unchanged) | View |
| 2020-02-14 3:59 pm Purchase | 13G | SPRINGWORKS THERAPEUTICS INC C SWTX | PERCEPTIVE ADVISORS LLC | 3,297,522 7.7% | 80,000 (+2.49%) | View |
| 2020-02-14 3:05 pm Purchase | 13G | SPRINGWORKS THERAPEUTICS INC C SWTX | BIOTECHNOLOGY VALUE FUND L P | 3,079,155 7.2% | 235,310 (+8.27%) | View |
| 2020-02-14 1:52 pm Purchase | 13G | SPRINGWORKS THERAPEUTICS INC C SWTX | PFIZER INC PFE | 4,593,847 10.7% | 4,593,847 (New Position) | View |
| 2019-09-26 4:06 pm Purchase | 13G | SPRINGWORKS THERAPEUTICS INC C SWTX | PERCEPTIVE ADVISORS LLC | 3,217,522 7.4% | 3,217,522 (New Position) | View |
| 2019-09-25 4:41 pm Purchase | 13D | SPRINGWORKS THERAPEUTICS INC C SWTX | ORBIMED ADVISORS LLC | 7,406,307 17.1% | 7,406,307 (New Position) | View |
| 2019-09-24 08:57 am Purchase | 13D | SPRINGWORKS THERAPEUTICS INC C SWTX | BC SW LP | 7,281,307 16.8% | 7,281,307 (New Position) | View |